Self-assembly of the cytoskeletal glial fibrillary acidic protein is inhibited by an isoform-specific C terminus

被引:28
作者
Nielsen, AL [1 ]
Jorgensen, AL [1 ]
机构
[1] Univ Aarhus, Dept Human Genet, DK-8000 Aarhus C, Denmark
关键词
D O I
10.1074/jbc.M406601200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The predominant isoform of glial fibrillary acidic protein (GFAP), GFAPalpha, is the characteristic building block of the cytoskeletal intermediate filaments in astrocytes. Isoform GFAPepsilon, produced by alternative splicing of the GFAP gene, includes a new tail domain that confers a presenilin binding capacity. We here show that the GFAPepsilon tail prevents GFAPepsilon homodimerization and homomeric filament formation, whereas the ability to form heterodimers and filaments with GFAPalpha is retained. Furthermore, GFAPepsilon shows decreased affinity for several GFAPalpha-interacting proteins. A GFAPepsilon tail mutation that results in gain of GFAPepsilon dimerization and filament formation abolishes presenilin binding. This mutation also abolishes interaction between the tail and the coiled-coil domain of GFAPepsilon. Together, this indicates that direct interaction between the coiled-coil and tail domains may serve as an inhibitory mechanism for homomeric dimerization and filament formation. We propose that the GFAPepsilon isoform represents a new functionally distinct component of GFAP intermediate filaments.
引用
收藏
页码:41537 / 41545
页数:9
相关论文
共 29 条
[1]  
BONGCAMRUDLOFF E, 1991, CANCER RES, V51, P1553
[2]   Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease [J].
Brenner, M ;
Johnson, AB ;
Boespflug-Tanguy, O ;
Rodriguez, D ;
Goldman, JE ;
Messing, A .
NATURE GENETICS, 2001, 27 (01) :117-120
[3]  
CHEN WJ, 1994, J CELL SCI, V107, P2299
[4]   Intermediate filament protein partnership in astrocytes [J].
Eliasson, C ;
Sahlgren, C ;
Berthold, CH ;
Stakeberg, J ;
Celis, JE ;
Betsholtz, C ;
Eriksson, JE ;
Pekny, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23996-24006
[5]   Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000) [J].
Eng, LF ;
Ghirnikar, RS ;
Lee, YL .
NEUROCHEMICAL RESEARCH, 2000, 25 (9-10) :1439-1451
[6]   The cytoskeleton and disease: Genetic disorders of intermediate filaments [J].
Fuchs, E .
ANNUAL REVIEW OF GENETICS, 1996, 30 :197-231
[7]   Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics [J].
Herrmann, H ;
Aebi, U .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (01) :79-90
[8]   Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms [J].
Hol, EM ;
Roelofs, RF ;
Moraal, E ;
Sonnemans, MAF ;
Sluijs, JA ;
Proper, EA ;
de Graan, PNE ;
Fischer, DF ;
van Leeuwen, FW .
MOLECULAR PSYCHIATRY, 2003, 8 (09) :786-796
[9]   Determination of the gene structure of human GFAP and absence of coding region mutations associated with frontotemporal dementia with parkinsonism linked to chromosome 17 [J].
Isaacs, A ;
Baker, M ;
Hutton, M .
GENOMICS, 1998, 51 (01) :152-154
[10]  
JOHNSON AB, 2002, INT J DEV NEUROSCI, V759, P1